PSA-velocity bei prostataerkrankungen

Translated title of the contribution: PSA velocity in diseases of the prostate

R. Thiel, J. D. Pearson, H. B. Carter

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Prostate-specific velocity (rate of change) is a method for assessing the risk of prostate cancer in an individual and for distinguishing prostatic adenoma from prostatic cancer. Using a PSA velocity (PSAV) cut-off point of 0.75 ng/ml per year, sensitivity among men with prostate cancer was 70% and specificity among men without prostate cancer was 95%. Therefore, the validity of PSAV is higher than the interpretation of a single PSA value. PSAV allows detection of prostate cancer an average of 5 years earlier than its clinical manifestation. In patients after radical prostatectomy, PSAV can help to distinguish local recurrence (<0.75 ng/ml/year) from distant metastasis (> 0.75 ng/ml/year). Currently, the validity of PSAV is low in staging and assessing the prognosis of prostate cancer. Routine use of this concept requires the analysis of several PSA values (preferably of the same assay) over a time span of 1.5 to 2 years.

Translated title of the contributionPSA velocity in diseases of the prostate
Original languageGerman
Pages (from-to)19-23
Number of pages5
JournalAktuelle Urologie
Issue number1
StatePublished - Feb 1998
Externally publishedYes


  • Prostate specific antigen
  • Review
  • Velocity

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'PSA velocity in diseases of the prostate'. Together they form a unique fingerprint.

Cite this